Clinical Trial Update: Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial of an investigational drug in combination with two chemotherapy drugs for locally recurrent or metastatic breast cancer has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Investigational Drug (name undisclosed)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 1, Phase 2 | Status: WITHDRAWN